Reduced-Intensity Conditioning followed by Allogeneic Hematopoietic Cell Transplantation for Adult Patients with Myelodysplastic Syndrome and Myeloproliferative Disorders-Reference-Cited by-同舟云学术

Reduced-Intensity Conditioning followed by Allogeneic Hematopoietic Cell Transplantation for Adult Patients with Myelodysplastic Syndrome and Myeloproliferative Disorders

Published:2008-02 Issue:2 Volume:14 Page:246-255
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Laport Ginna G.,Sandmaier Brenda M.,Storer Barry E.,Scott Bart L.,Stuart Monic J.,Lange Thoralf,Maris Michael B.,Agura Edward D.,Chauncey Thomas R.,Wong Ruby M.,Forman Stephen J.,Petersen Finn B.,Wade James C.,Epner Elliot,Bruno Benedetto,Bethge Wolfgang A.,Curtin Peter T.,Maloney David G.,Blume Karl G.,Storb Rainer F.

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference35 articles.

1. Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT);de Witte;Br J Haematol,2000

2. Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia;Sierra;Blood,2002

3. Allogeneic hematopoietic stem cell transplantation for myelofibrosis;Deeg;Blood,2003

4. Hematopoietic stem-cell transplantation for treatment-related leukemia or myelodysplasia;Witherspoon;J Clin Oncol,2001

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current challenges in conditioning regimens for MDS transplantation;Blood Reviews;2024-09

2. ACR–ARS Practice Parameter for the Performance of Total Body Irradiation;American Journal of Clinical Oncology;2023-03-13

3. Role of Bcl‐2 inhibition in myelodysplastic syndromes;International Journal of Cancer;2022-12-08

4. Myelodysplastic syndromes;Nature Reviews Disease Primers;2022-11-17

5. Allogeneic Hematopoietic Stem Cell Transplantation for Mixed or Overlap Myelodysplastic/Myeloproliferative Disorders;Frontiers in Oncology;2022-08-05